Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 31 01 2020
revised: 13 06 2020
accepted: 17 06 2020
pubmed: 28 6 2020
medline: 14 8 2021
entrez: 28 6 2020
Statut: ppublish

Résumé

The rise of vaping in adolescents, the recent entrance of new inhaled nicotine products such as iQOS on the market and e-cigarette or vaping product use-associated lung injury cases has created concern for the use of inhaled non-combustible nicotine products. This narrative review discusses recent experimental in vivo studies that utilize human, rat and mouse models to understand the pharmacological impact of nicotine from non-combustible products. The search engine PubMed was utilized with the following search terms: inhaled nicotine, nicotine e-cigarette, heated tobacco products, iQOS, electronic cigarette, nicotine inhaler, nicotine vaping. This review highlights recent primary in vivo studies of inhaled nicotine administration experimental paradigms that occurred in laboratory settings using human and rodent (rats and mice) models that have been published from January 2017-December 2019. The pharmacokinetics of nicotine via e-cigarettes is influenced by the PG/VG and flavor constituents in e-liquids, the presence of nicotine salts in e-liquids, puff topography of nicotine and tobacco product users and the power of the e-cigarette device. The pharmacodynamic impact of inhaled nicotine has cardiovascular, pulmonary and central nervous system implications. The articles reviewed here highlight the importance of both animal and human models to fully understand the impact of inhaled nicotine pharmacology There is a need for more rodent pharmacokinetic inhaled nicotine studies to understand the influences of factors such as flavor and nicotine salts. Additionally, consensus on nicotine measurement in both human and rodent studies is greatly needed.

Identifiants

pubmed: 32592708
pii: S0028-3908(20)30286-0
doi: 10.1016/j.neuropharm.2020.108218
pmc: PMC7529934
mid: NIHMS1610916
pii:
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108218

Subventions

Organisme : NIDA NIH HHS
ID : R25 DA035163
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007238
Pays : United States
Organisme : NIDA NIH HHS
ID : U54 DA036151
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

J Pharmacol Exp Ther. 1997 Jul;282(1):7-13
pubmed: 9223534
PLoS One. 2019 Jul 25;14(7):e0220300
pubmed: 31344110
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:1-8
pubmed: 28347687
Drug Alcohol Depend. 2019 Oct 1;203:27-34
pubmed: 31401532
Inhal Toxicol. 2018 Nov - Dec;30(13-14):553-567
pubmed: 30849254
Nicotine Tob Res. 2016 May;18(5):720-3
pubmed: 26377515
Trends Cardiovasc Med. 2016 Aug;26(6):515-23
pubmed: 27079891
Ann N Y Acad Sci. 2017 Apr;1394(1):5-30
pubmed: 26774031
J Am Heart Assoc. 2017 Aug 30;6(9):
pubmed: 28855171
FASEB Bioadv. 2019 Oct;1(10):609-623
pubmed: 31825014
Transl Res. 2019 May;207:70-82
pubmed: 30653941
J Nucl Med. 2020 Jun;61(6):928-930
pubmed: 31676729
Drug Alcohol Depend. 2019 Oct 1;203:99-106
pubmed: 31434028
Eur J Clin Pharmacol. 2000 Jan;55(10):737-41
pubmed: 10663452
Oral Dis. 2017 Nov;23(8):1052-1057
pubmed: 28168771
Psychopharmacology (Berl). 2018 Apr;235(4):1083-1092
pubmed: 29306962
Psychopharmacology (Berl). 2020 Feb;237(2):491-502
pubmed: 31773209
JAMA Netw Open. 2019 Nov 1;2(11):e1915494
pubmed: 31730180
Regul Toxicol Pharmacol. 2018 Oct;98:250-256
pubmed: 30053435
Annu Rev Pharmacol Toxicol. 2007;47:699-729
pubmed: 17009926
J Neurosci Methods. 2019 Oct 1;326:108376
pubmed: 31361999
J Pharmacol Exp Ther. 2008 Apr;325(1):302-12
pubmed: 18184829
Curr Neuropharmacol. 2018;16(4):438-459
pubmed: 29046158
Food Chem Toxicol. 2018 Jun;116(Pt B):388-413
pubmed: 29654848
Am J Addict. 2019 Sep;28(5):361-366
pubmed: 31066987
Food Chem Toxicol. 2018 May;115:284-301
pubmed: 29545142
Addiction. 2019 Jul;114(7):1236-1248
pubmed: 30851137
Physiol Rev. 2009 Jan;89(1):73-120
pubmed: 19126755
J Neurosci. 1993 Apr;13(4):1551-68
pubmed: 8463835
Psychopharmacology (Berl). 2018 Jul;235(7):1897-1905
pubmed: 29549391
Tob Regul Sci. 2017 Apr;3(Suppl 1):S72-S83
pubmed: 28966952
Neuropharmacology. 2012 Aug;63(2):235-41
pubmed: 22480616
Neuropharmacology. 2017 May 15;118:38-45
pubmed: 28279662
Drug Alcohol Depend. 2019 Nov 1;204:107504
pubmed: 31476643
Am J Physiol Regul Integr Comp Physiol. 2018 Jun 1;314(6):R834-R847
pubmed: 29384700
Exp Clin Psychopharmacol. 2019 Oct;27(5):443-454
pubmed: 30777773
Nicotine Tob Res. 2020 Apr 21;22(5):806-813
pubmed: 30997500
J Physiol. 2015 Aug 15;593(16):3397-412
pubmed: 26018031
Ann N Y Acad Sci. 2014 May;1316:53-70
pubmed: 24690001
Cardiovasc Toxicol. 2019 Oct;19(5):441-450
pubmed: 30963443
Exp Clin Psychopharmacol. 2020 Apr;28(2):235-244
pubmed: 31259592
Drug Alcohol Depend. 2018 Jul 1;188:193-199
pubmed: 29778773
Drug Alcohol Depend. 2017 Sep 1;178:391-398
pubmed: 28704768
Nicotine Tob Res. 2015 Jul;17(7):847-54
pubmed: 25481917
J Addict Res Ther. 2011 Apr 20;S1(1):
pubmed: 22454789
Intern Emerg Med. 2019 Sep;14(6):853-861
pubmed: 30712148
Nicotine Tob Res. 2017 Nov 7;19(12):1531-1535
pubmed: 27663781
Psychopharmacology (Berl). 2000 Apr;149(3):198-202
pubmed: 10823399
Nicotine Tob Res. 2018 Jan 5;20(2):271-274
pubmed: 28371890
Am J Otolaryngol. 2019 Jan - Feb;40(1):89-92
pubmed: 30472132
Tob Control. 2019 Nov;28(6):676-677
pubmed: 30194085
Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L662-L672
pubmed: 30091379
J Pharmacol Exp Ther. 2009 Aug;330(2):541-9
pubmed: 19435931
MMWR Morb Mortal Wkly Rep. 2019 Oct 04;68(39):860-864
pubmed: 31581168
J Psychopharmacol. 2019 Dec;33(12):1600-1609
pubmed: 31542980
Nicotine Tob Res. 2017 Sep 1;19(9):1005-1015
pubmed: 28379511
Methods Mol Biol. 2012;929:583-600
pubmed: 23007443
Vasc Health Risk Manag. 2019 Jun 21;15:159-174
pubmed: 31417268
Tob Control. 2018 Nov;27(Suppl 1):s13-s19
pubmed: 30206183
Neuropharmacology. 2009 Jan;56(1):237-46
pubmed: 18723036
Tob Control. 2018 Nov;27(Suppl 1):s1-s6
pubmed: 30352841
Oncol Lett. 2018 Aug;16(2):1375-1382
pubmed: 30008813
J Endocr Soc. 2019 Sep 05;3(10):1907-1916
pubmed: 31598571
Tob Control. 2014 May;23 Suppl 2:ii30-5
pubmed: 24732160
PLoS One. 2015 Feb 09;10(2):e0117222
pubmed: 25664463
Chem Res Toxicol. 2018 Jun 18;31(6):431-434
pubmed: 29775302
Exp Clin Psychopharmacol. 2017 Oct;25(5):380-392
pubmed: 29048187
Nicotine Tob Res. 2015 Feb;17(2):150-7
pubmed: 25187061
Respir Res. 2018 Aug 31;19(1):164
pubmed: 30170593
J Mol Evol. 1995 Feb;40(2):155-72
pubmed: 7699721
Front Public Health. 2019 Oct 10;7:287
pubmed: 31649912
J Appl Physiol (1985). 2018 Mar 1;124(3):573-582
pubmed: 29097631
Arch Gen Psychiatry. 2006 Aug;63(8):907-15
pubmed: 16894067
Addiction. 2020 Apr;115(4):757-767
pubmed: 31691397
Inhal Toxicol. 2017 Apr;29(5):197-205
pubmed: 28651446
PLoS One. 2015 Sep 10;10(9):e0137070
pubmed: 26355604
Am J Physiol Lung Cell Mol Physiol. 2019 Jan 1;316(1):L94-L104
pubmed: 30358437
J Hypertens. 2019 Jan;37(1):154-166
pubmed: 30063637
BMJ. 2019 Sep 30;366:l5275
pubmed: 31570493
J Am Heart Assoc. 2018 Jul 18;7(15):
pubmed: 30021806
Tob Regul Sci. 2016 Oct;2(4):363-376
pubmed: 28393086
Nicotine Tob Res. 2020 Apr 21;22(5):791-797
pubmed: 31403695
BMC Public Health. 2016 Jul 30;16:674
pubmed: 27475060
Drug Alcohol Depend. 2019 Jan 1;194:395-400
pubmed: 30497057
Nicotine Tob Res. 2020 Apr 21;22(5):771-781
pubmed: 30995302
Tob Control. 2017 Mar;26(e1):e23-e28
pubmed: 27729564
Psychopharmacology (Berl). 2019 Dec;236(12):3593-3599
pubmed: 31302720
Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H445-H459
pubmed: 31172811
Front Pharmacol. 2019 Aug 12;10:885
pubmed: 31456684
Nicotine Tob Res. 2018 Mar 6;20(4):425-433
pubmed: 28460123
Nicotine Tob Res. 2015 Oct;17(10):1242-6
pubmed: 25744966
Brain Res Bull. 2018 Apr;138:56-63
pubmed: 28528203
Sci Rep. 2018 Jul 10;8(1):10378
pubmed: 29991814
Nature. 1998 Jan 8;391(6663):173-7
pubmed: 9428762
Drug Alcohol Depend. 2017 Mar 01;172:80-87
pubmed: 28157590
JAMA. 2019 Nov 5;:
pubmed: 31688912
Psychopharmacology (Berl). 2020 Mar;237(3):613-625
pubmed: 31760460
Brain Res Brain Res Rev. 1998 May;26(2-3):198-216
pubmed: 9651527
J Nucl Med. 2005 Sep;46(9):1466-72
pubmed: 16157529
Am J Prev Med. 2017 Aug;53(2):139-151
pubmed: 28318902
Addiction. 2020 Jun;115(6):1149-1159
pubmed: 31837232
Exp Clin Psychopharmacol. 2019 Dec 19;:
pubmed: 31855003
Nicotine Tob Res. 2017 Apr 1;19(4):469-476
pubmed: 27613914
Sci Rep. 2019 Mar 11;9(1):4085
pubmed: 30858470
Am J Physiol Lung Cell Mol Physiol. 2017 Jul 1;313(1):L67-L79
pubmed: 28360111
Nicotine Tob Res. 2018 Mar 6;20(4):458-465
pubmed: 28482017
Cardiovasc Drugs Ther. 1997 Jan;10(6):657-65
pubmed: 9110108
Int J Environ Res Public Health. 2017 Feb 15;14(2):
pubmed: 28212302
Annu Rev Neurosci. 2011;34:105-30
pubmed: 21438686
Int J Environ Res Public Health. 2018 Dec 18;15(12):
pubmed: 30567400
Tob Control. 2014 May;23 Suppl 2:ii23-9
pubmed: 24732159
Int J Hyg Environ Health. 2018 Mar;221(2):191-198
pubmed: 29129555
Toxicol Pathol. 1995 Mar-Apr;23(2):115-23
pubmed: 7569664
Vasc Med. 2018 Oct;23(5):419-425
pubmed: 29985113
Psychopharmacology (Berl). 2017 Mar;234(5):773-779
pubmed: 28070620
Cardiovasc Res. 2020 Jan 1;116(1):40-50
pubmed: 31696222
Food Chem Toxicol. 2019 Apr;126:113-141
pubmed: 30763686
Drug Alcohol Depend. 2017 Nov 1;180:193-199
pubmed: 28915478
Tob Control. 2019 Dec 17;:
pubmed: 31848312
Sci Rep. 2017 Dec 5;7(1):16974
pubmed: 29209071
Nicotine Tob Res. 2018 Jul 9;20(8):993-997
pubmed: 29059377
Respir Res. 2018 May 14;19(1):78
pubmed: 29754582
N Engl J Med. 2018 Sep 20;379(12):1099-1102
pubmed: 30134127
Handb Exp Pharmacol. 2009;(192):29-60
pubmed: 19184645
Tob Control. 2020 Jul;29(4):461-463
pubmed: 31175225
Nicotine Tob Res. 2012 Oct;14(10):1127-39
pubmed: 22377934
Drug Alcohol Depend. 2019 May 1;198:54-62
pubmed: 30878767
Regul Toxicol Pharmacol. 2018 Dec;100:25-34
pubmed: 30201538

Auteurs

Asti Jackson (A)

Department of Psychiatry, Yale School of Medicine, United States. Electronic address: asti.jackson@yale.edu.

Ben Grobman (B)

Department of Psychiatry, Yale School of Medicine, United States.

Suchitra Krishnan-Sarin (S)

Department of Psychiatry, Yale School of Medicine, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH